Eli Lilly CEO discusses its coronavirus antibody drug and the latest on its breast cancer treatment

Eli Lilly CEO and Chairman Dave Ricks joined CNBC's Jim Cramer on Monday, discussing the results of its study on its breast cancer treatment Verzenio. Ricks also touted the "proof-of-concept" data for its Covid-19 antibody treatment.
Mon, Sep 21 20206:54 PM EDT

watch now
CNBC ProJim Cramer analyzes the investment case for Nano-X Imaging and Shift4 Payments
watch now
CNBC ProHistorical charts suggest this is a winning S&P 500 trade, says Jim Cramer
watch now
CNBC ProJim Cramer offers a playbook for soaring tech stocks like Zoom, Cloudflare and Snowflake
watch now
CNBC ProLiz Young's advice to investors: 'Hang on to your seats and wait it out'
watch now
CNBC ProThere will be great buying opportunity with both vaccine and fiscal stimulus: David Rosenberg